News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
The impact our circadian rhythm has on immunotherapy – Cancer Research Institute
Photo of Ping Chih-Ho from medicalxpress.com
Sep 29, 2024, 15:11

The impact our circadian rhythm has on immunotherapy – Cancer Research Institute

Cancer Research Institute posted on LinkedIn about recent paper by Sahana Sitaraman, titled “The Circadian Clock Tells the Right Time for Immunotherapy” published on The Scientist.

The impact our circadian rhythm has on immunotherapy - Cancer Research Institute

“According to new research from CRI Lloyd J. Old STAR Dr. Ping Chih-Ho of University of Lausanne and Ludwig Cancer Research, the efficacy of immunotherapy is influenced by the time of day it is administered. This study, published in Cell by Cell Press, demonstrates how giving immunotherapy when the tumor microenvironment is most susceptible to T cells enhances treatment efficacy in mice. Read more about the impact our circadian rhythm has on immunotherapy, in The Scientist.”

Source: Cancer Research Institute/LinkedIn

Ping Chih-Ho is a Full Professor at the University of Lausanne and a Full Member of Ludwig Cancer Research. He is also a Co-Founder of Pilatus Biosciences. His research specializes in the study of immunometabolism, particularly in T cells and macrophages.

 

cancer Cancer Research Institute Cell by Cell Press CRI Lloyd J. Old Ludwig Cancer Research OncoDaily Oncology Ping-Chih Ho Sahana Sitaraman The Scientist University of Lausanne
Special Coverage
Blog
Nov 13, 2024, 11:25
Some information you should know about lung cancer - American Cancer Society
Insight
Nov 13, 2024, 11:10
Myeloma Paper of the Day, November 13th, suggested by Robert Orlowski
Blog
Nov 13, 2024, 11:01
LGCW2024 session on Galvanising African cancer research building a strong cancer workforce - AORTIC- Africa
Blog
Nov 13, 2024, 10:59
Bernard Fox received SITC lifetime achievement award
Blog
Nov 13, 2024, 10:54
Hear Her campaign Increasing awareness about lung cancer in women
Blog
Nov 13, 2024, 10:52
Johnson & Johnson Seeks Approval for DARZALEX FASPRO as Subcutaneous Monotherapy for High-Risk Smoldering Multiple Myeloma
Blog
Nov 13, 2024, 10:47
FDA approves obecabtagene autoleucel for relapsed or refractory B-cell precursor ALL
Blog
Nov 13, 2024, 10:45
OncoInfluencers to Follow on Social Media: Dr. Nitin Jain
Insight
Nov 13, 2024, 10:37
UCLA: Combination approach shows promise for treating rare, aggressive cancers
Opinion
Nov 13, 2024, 10:32
The 6th Biennial Miami Epigenetics and Cancer Symposium to be held in Sylvester Comprehensive Cancer Center
Blog
Nov 13, 2024, 10:16
Highlights from IU Simon Comprehensive Cancer Center’s End Lung Cancer Now Gathering - Hoosier Cancer Research Network
Blog
Nov 13, 2024, 10:06
A first-in-class Antibody Drug Conjugate that works by directly stimulating the immune system